ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,746Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 1111

$1.55M Total Retail Price of All Prescriptions

Rank: 13 out of 1111

985 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 985 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 985 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 19,743 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
CITALOPRAM HBR 801 565 1 14
LEVOTHYROXINE SODIUM 777 567 2 3
HYDROCODONE-ACETAMINOPHEN 762 691 S3 3 1
SIMVASTATIN 743 581 4 5
LISINOPRIL 673 544 5 2
OMEPRAZOLE 648 413 6 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 639 538 7 23
AMLODIPINE BESYLATE 621 557 8 7
METFORMIN HCL 582 505 9 8
FUROSEMIDE 563 500 10 6
POTASSIUM CHLORIDE 508 439 11 9
METOPROLOL TARTRATE 454 384 12 12
FLUTICASONE PROPIONATE 417 260 13 27
CRESTOR 403 352 14 33
PRAVASTATIN SODIUM 383 344 15 17
ATORVASTATIN CALCIUM 371 309 16 15
ALENDRONATE SODIUM 363 256 17 35
TRAMADOL HCL 354 295 18 13
HYDROCHLOROTHIAZIDE 347 263 19 11
GABAPENTIN 345 256 20 10
WARFARIN SODIUM 339 249 21 19
NAMENDA 311 225 22 31
DONEPEZIL HCL 299 248 23 25
CARVEDILOL 295 263 24 21
ZOLPIDEM TARTRATE 284 206 25 16
METOPROLOL SUCCINATE 249 233 26 20
MELOXICAM 248 209 27 18
DIOVAN HCT 235 234 28 94
SERTRALINE HCL 227 134 29 24
ADVAIR DISKUS 222 180 30 43
SPIRIVA 197 184 31 53
NEXIUM 191 116 32 26
FLUOXETINE HCL 183 139 33 44
AMLODIPINE BESYLATE-BENAZEPRIL 171 163 34 67
ALLOPURINOL 170 102 35 36
DICLOFENAC SODIUM 165 127 36 108
TAMSULOSIN HCL 164 136 37 28
CLOPIDOGREL 152 149 38 30
CIPROFLOXACIN HCL 151 129 39 58
TOPIRAMATE 150 60 40 177
CYMBALTA 145 93 41 40
PANTOPRAZOLE SODIUM 144 128 42 50
DOXAZOSIN MESYLATE 143 123 43 87
LOSARTAN POTASSIUM 142 135 44 34
PAROXETINE HCL 139 90 45 55
PLAVIX 130 129 46 49
DIGOXIN 129 99 47 47
POLYETHYLENE GLYCOL 3350 127 95 48 45
AZITHROMYCIN 127 100 48 39
ISOSORBIDE MONONITRATE ER 125 120 50 73
TRAZODONE HCL 123 73 51 32
METHYLPREDNISOLONE 123 105 51 93
PROAIR HFA 123 86 51 38
CLONIDINE HCL 118 83 54 42
BACLOFEN 116 45 55 119
RANITIDINE HCL 115 67 56 29
DOXYCYCLINE HYCLATE 112 94 57 113
LEVOFLOXACIN 111 86 58 88
VERAPAMIL ER 109 102 59 100
DIOVAN 109 109 59 51
DILTIAZEM 24HR CD 107 82 61 152
PREDNISONE 104 84 62 48
GLYBURIDE 103 94 R 63 59
NAPROXEN 103 89 63 85
OXYBUTYNIN CHLORIDE 103 57 63 110
LOSARTAN-HYDROCHLOROTHIAZIDE 102 94 66 72
TRIAMTERENE-HCTZ 102 90 66 80
ATENOLOL 100 98 68 22
LIPITOR 100 64 68 116
RISPERIDONE 97 49 70 60
FENTANYL 92 79 S2 71 65
ABILIFY 91 0 72 123
FINASTERIDE 86 86 73 115
SPIRONOLACTONE 86 60 73 83
CYCLOBENZAPRINE HCL 83 36 R 75 37
SINGULAIR 82 61 76 112
SUCRALFATE 81 53 77 125
LAMOTRIGINE 81 0 77 172
PRADAXA 78 72 79 247
EXELON 77 57 80 121
ENALAPRIL MALEATE 77 50 80 56
LEVETIRACETAM 75 23 82 111
PREMARIN 74 48 R 83 90
AMITRIPTYLINE HCL 73 62 R 84 64
NYSTATIN 73 61 84 151
IBUPROFEN 73 37 84 66
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 55 87 71
KLOR-CON M20 71 60 88 79
CARBIDOPA-LEVODOPA 69 57 89 101
MIRTAZAPINE 67 34 90 52
RAMIPRIL 64 64 91 168
TRIAMCINOLONE ACETONIDE 62 41 92 128
ROPINIROLE HCL 60 54 93 68
ZETIA 59 46 94 109
ACTOS 58 50 95 98
LYRICA 57 44 96 62
DILTIAZEM ER 56 36 97 158
DETROL LA 56 16 97 139
LEVEMIR FLEXPEN 56 31 97 178
TERAZOSIN HCL 56 53 97 127
AMIODARONE HCL 56 56 97 145
OLANZAPINE 56 35 97 117
GLIMEPIRIDE 56 56 97 61
PROMETHAZINE HCL 56 30 R 97 69
ESCITALOPRAM OXALATE 55 17 105 78
SYNTHROID 55 55 105 63
BUMETANIDE 55 55 105 173
FAMOTIDINE 55 44 105 77
FLUCONAZOLE 54 40 109 195
QUETIAPINE FUMARATE 54 25 109 76
GLYBURIDE-METFORMIN HCL 53 53 R 111 187
PHENYTOIN SODIUM EXTENDED 51 26 112 126
DILTIAZEM 24HR ER 50 47 113 259
CARBAMAZEPINE 50 14 113 196
BUPROPION HCL SR 50 27 113 150
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.